Phase 2b Trial for Mitochondrial Diseases has Begun
source: pixabay.com

Phase 2b Trial for Mitochondrial Diseases has Begun

Khondrion has just announced that the very first patient has been dosed in their Phase 2b study for mitochondrial diseases called KHENERGYZE. This patient population has a high unmet need…

Continue Reading Phase 2b Trial for Mitochondrial Diseases has Begun
Close Menu